Literature DB >> 27431292

Inducible ablation of dopamine D2 receptors in adult mice impairs locomotion, motor skill learning and leads to severe parkinsonism.

E P Bello1, R Casas-Cordero1, G L Galiñanes2, E Casey1, M A Belluscio2, V Rodríguez1, D Noaín1, M G Murer2,3, M Rubinstein1,4.   

Abstract

Motor execution and planning are tightly regulated by dopamine D1 and D2 receptors present in basal ganglia circuits. Although stimulation of D1 receptors is known to enhance motor function, the global effect of D2 receptor (D2R) stimulation or blockade remains highly controversial, with studies showing increasing, decreasing or no changes in motor activity. Moreover, pharmacological and genetic attempts to block or eliminate D2R have led to controversial results that questioned the importance of D2R in motor function. In this study, we generated an inducible Drd2 null-allele mouse strain that circumvented developmental compensations found in constitutive Drd2-/- mice and allowed us to directly evaluate the participation of D2R in spontaneous locomotor activity and motor learning. We have found that loss of D2R during adulthood causes severe motor impairments, including hypolocomotion, deficits in motor coordination, impaired learning of new motor routines and spontaneous catatonia. Moreover, severe motor impairment, resting tremor and abnormal gait and posture, phenotypes reminiscent of Parkinson's disease, were evident when the mutation was induced in aged mice. Altogether, the conditional Drd2 knockout model studied here revealed the overall fundamental contribution of D2R in motor functions and explains some of the side effects elicited by D2R blockers when used in neurological and psychiatric conditions, including schizophrenia, bipolar disorder, Tourette's syndrome, dementia, alcohol-induced delusions and obsessive-compulsive disorder.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27431292     DOI: 10.1038/mp.2016.105

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  62 in total

1.  Disruption of the D2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice.

Authors:  G Díaz-Torga; C Feierstein; C Libertun; D Gelman; M A Kelly; M J Low; M Rubinstein; D Becú-Villalobos
Journal:  Endocrinology       Date:  2002-04       Impact factor: 4.736

2.  Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry.

Authors:  Alexxai V Kravitz; Benjamin S Freeze; Philip R L Parker; Kenneth Kay; Myo T Thwin; Karl Deisseroth; Anatol C Kreitzer
Journal:  Nature       Date:  2010-07-07       Impact factor: 49.962

3.  Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons.

Authors:  Zhongfeng Wang; Li Kai; Michelle Day; Jennifer Ronesi; Henry H Yin; Jun Ding; Tatiana Tkatch; David M Lovinger; D James Surmeier
Journal:  Neuron       Date:  2006-05-04       Impact factor: 17.173

4.  Dopamine depletion increases the power and coherence of beta-oscillations in the cerebral cortex and subthalamic nucleus of the awake rat.

Authors:  Andrew Sharott; Peter J Magill; Daniel Harnack; Andreas Kupsch; Wassilios Meissner; Peter Brown
Journal:  Eur J Neurosci       Date:  2005-03       Impact factor: 3.386

5.  Disrupted dopamine transmission and the emergence of exaggerated beta oscillations in subthalamic nucleus and cerebral cortex.

Authors:  Nicolas Mallet; Alek Pogosyan; Andrew Sharott; Jozsef Csicsvari; J Paul Bolam; Peter Brown; Peter J Magill
Journal:  J Neurosci       Date:  2008-04-30       Impact factor: 6.167

6.  Lesion to the nigrostriatal dopamine system disrupts stimulus-response habit formation.

Authors:  Alexis Faure; Ulrike Haberland; Françoise Condé; Nicole El Massioui
Journal:  J Neurosci       Date:  2005-03-16       Impact factor: 6.167

7.  Cortical slow oscillatory activity is reflected in the membrane potential and spike trains of striatal neurons in rats with chronic nigrostriatal lesions.

Authors:  K Y Tseng; F Kasanetz; L Kargieman; L A Riquelme; M G Murer
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

8.  Effect of deep brain stimulation and L-Dopa on electrocortical rhythms related to movement in Parkinson's disease.

Authors:  D Devos; L Defebvre
Journal:  Prog Brain Res       Date:  2006       Impact factor: 2.453

9.  Presynaptic D2 dopamine receptors control long-term depression expression and memory processes in the temporal hippocampus.

Authors:  Jill Rocchetti; Elsa Isingrini; Gregory Dal Bo; Sara Sagheby; Aurore Menegaux; François Tronche; Daniel Levesque; Luc Moquin; Alain Gratton; Tak Pan Wong; Marcelo Rubinstein; Bruno Giros
Journal:  Biol Psychiatry       Date:  2014-03-20       Impact factor: 13.382

10.  Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons.

Authors:  Sarah Threlfell; Tatjana Lalic; Nicola J Platt; Katie A Jennings; Karl Deisseroth; Stephanie J Cragg
Journal:  Neuron       Date:  2012-07-12       Impact factor: 17.173

View more
  16 in total

1.  Going Back to Kahlbaum's Psychomotor (and GABAergic) Origins: Is Catatonia More Than Just a Motor and Dopaminergic Syndrome?

Authors:  Dusan Hirjak; Katharina M Kubera; R Christian Wolf; Georg Northoff
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

2.  Prenatal nicotine exposure decreases the release of dopamine in the medial frontal cortex and induces atomoxetine-responsive neurobehavioral deficits in mice.

Authors:  Tursun Alkam; Takayoshi Mamiya; Nami Kimura; Aya Yoshida; Daisuke Kihara; Yuki Tsunoda; Yuki Aoyama; Masayuki Hiramatsu; Hyoung-Chun Kim; Toshitaka Nabeshima
Journal:  Psychopharmacology (Berl)       Date:  2017-03-23       Impact factor: 4.530

3.  Finasteride inhibited brain dopaminergic system and open-field behaviors in adolescent male rats.

Authors:  Li Li; Yun-Xiao Kang; Xiao-Ming Ji; Ying-Kun Li; Shuang-Cheng Li; Xiang-Jian Zhang; Hui-Xian Cui; Ge-Ming Shi
Journal:  CNS Neurosci Ther       Date:  2017-12-06       Impact factor: 5.243

Review 4.  Current Concepts on the Physiopathological Relevance of Dopaminergic Receptors.

Authors:  Ada Ledonne; Nicola B Mercuri
Journal:  Front Cell Neurosci       Date:  2017-02-08       Impact factor: 5.505

5.  Striatal But Not Extrastriatal Dopamine Receptors Are Critical to Dopaminergic Motor Stimulation.

Authors:  Yuhan Wang; Fu-Ming Zhou
Journal:  Front Pharmacol       Date:  2017-12-21       Impact factor: 5.810

6.  Essential Control of the Function of the Striatopallidal Neuron by Pre-coupled Complexes of Adenosine A2A-Dopamine D2 Receptor Heterotetramers and Adenylyl Cyclase.

Authors:  Sergi Ferré; Jordi Bonaventura; Wendy Zhu; Candice Hatcher-Solis; Jaume Taura; César Quiroz; Ning-Sheng Cai; Estefanía Moreno; Verónica Casadó-Anguera; Alexxai V Kravitz; Kimberly R Thompson; Dardo G Tomasi; Gemma Navarro; Arnau Cordomí; Leonardo Pardo; Carme Lluís; Carmen W Dessauer; Nora D Volkow; Vicent Casadó; Francisco Ciruela; Diomedes E Logothetis; Daniel Zwilling
Journal:  Front Pharmacol       Date:  2018-04-09       Impact factor: 5.810

7.  Light/dark phase-dependent spontaneous activity is maintained in dopamine-deficient mice.

Authors:  Masayo Fujita; Yoko Hagino; Taishi Takeda; Shinya Kasai; Miho Tanaka; Yukio Takamatsu; Kazuto Kobayashi; Kazutaka Ikeda
Journal:  Mol Brain       Date:  2017-10-16       Impact factor: 4.041

Review 8.  Spiny Projection Neuron Dynamics in Toxin and Transgenic Models of Parkinson's Disease.

Authors:  Yijuan Du; Steven M Graves
Journal:  Front Neural Circuits       Date:  2019-03-15       Impact factor: 3.492

9.  Single-Cell Analysis of Foxp1-Driven Mechanisms Essential for Striatal Development.

Authors:  Ashley G Anderson; Ashwinikumar Kulkarni; Matthew Harper; Genevieve Konopka
Journal:  Cell Rep       Date:  2020-03-03       Impact factor: 9.423

10.  Analysis of a conditional gene trap reveals that tbx5a is required for heart regeneration in zebrafish.

Authors:  Viktorija Grajevskaja; Diana Camerota; Gianfranco Bellipanni; Jorune Balciuniene; Darius Balciunas
Journal:  PLoS One       Date:  2018-06-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.